Adatanserin
A serotonin receptor antagonist and partial agonist
| Adatanserin | |
|---|---|
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
Adatanserin is a chemical compound that acts as a serotonin receptor antagonist and partial agonist. It has been studied for its potential therapeutic effects in various neurological disorders.
Pharmacology
Adatanserin primarily targets the 5-HT2A receptor and the 5-HT1A receptor. As a 5-HT2A receptor antagonist, it blocks the action of serotonin at this receptor, which is thought to contribute to its potential antidepressant and anxiolytic effects. As a partial agonist at the 5-HT1A receptor, adatanserin can modulate serotonin activity, which may also play a role in its therapeutic profile.
Mechanism of Action
The mechanism of action of adatanserin involves its interaction with serotonin receptors in the central nervous system. By antagonizing the 5-HT2A receptor, adatanserin may reduce the excitatory effects of serotonin, which can be beneficial in conditions characterized by excessive neuronal activity. Its partial agonist activity at the 5-HT1A receptor may help stabilize mood and reduce anxiety by modulating serotonin levels.
Potential Therapeutic Uses
Adatanserin has been investigated for its potential use in treating depression, anxiety disorders, and other psychiatric conditions. Its dual action on serotonin receptors makes it a candidate for addressing the complex neurochemical imbalances associated with these disorders.
Synthesis
The synthesis of adatanserin involves several chemical steps, starting from basic organic compounds. The process includes the formation of the indole ring and the attachment of the piperazine moiety, which are crucial for its activity as a serotonin receptor modulator. The detailed synthetic pathway is illustrated in the accompanying diagram.
Related pages
Gallery
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD